参考文献
-
1) Molybdenum Nanoparticles Alleviate MC903-Induced Atopic Dermatitis-Like Symptoms in Mice by Modulating the ROS-Mediated NF-κB and Nrf2 /HO-1 Signaling Pathways.
-
2) Enhancing the Inhibition of Breast Cancer Growth Through Synergistic Modulation of the Tumor Microenvironment Using Combined Nano-Delivery Systems.
-
3) Magnetic Graphene Oxide Nanocomposites Boosts Craniomaxillofacial Bone Regeneration by Modulating circAars/miR-128-3p/SMAD5 Signaling Axis.
-
4) Efficient Sequential Co-Delivery Nanosystem for Inhibition of Tumor and Tumor-Associated Fibroblast-Induced Resistance and Metastasis.
-
5) Anti-miR-141-3p maintains homeostasis between autophagy and apoptosis by targeting Yy1 in the fetal lumbosacral defecation center of rats.
-
6) Histone modifications and Sp1 promote GPR160 expression in bone cancer pain within rodent models.
-
7) Eicosapentaenoic acid induces macrophage Mox polarization to prevent diabetic cardiomyopathy.
-
8) Microglial Activation and Hypothalamic Structural Plasticity in HFD Obesity: Insights from Semaglutide and Minocycline.
-
9) YOD1 sustains NOD2-mediated protective signaling in colitis by stabilizing RIPK2.
-
10) Multi-omic profiling reveals potential biomarkers of hepatocellular carcinoma prognosis and therapy response among mitochondria-associated cell death genes in the context of 3P medicine.
-
11) TrSnt2-mediated histone H3 deacetylation governs mitophagy, ROS accumulation, ergosterol synthesis, and pathogenicity in Trichothecium roseum.
製品: 1Year: 2024ジャーナル: POSTHARVEST BIOL TECImpactFactor: 6.400DOI: 10.1016/j.postharvbio.2024.113081 -
12) LncRNA MFRL regulates the phenotypic switch of vascular smooth muscle cells to attenuate arterial remodeling by encoding a novel micropeptide MFRLP.
-
13) USP53 Affects the Proliferation and Apoptosis of Breast Cancer Cells by Regulating the Ubiquitination Level of ZMYND11.
-
14) Mechano-regulation of GLP-1 production by Piezo1 in intestinal L cells.
-
15) DRD4 promotes chemo-resistance and cancer stem cell-like phenotypes by mediating the activation of the Akt/β-catenin signaling axis in liver cancer.